GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $6.27 $8.02 Friday, 19th Apr 2024 ARDX stock ended at $6.48. This is 0.621% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.63% from a day low at $6.27 to a day high of $6.56.
90 days $6.27 $10.13
52 weeks $3.16 $10.13

Historical Ardelyx prices

Date Open High Low Close Volume
2023-07-05 $3.33 $3.46 $3.29 $3.40 3 601 220
2023-07-03 $3.40 $3.41 $3.29 $3.30 2 714 302
2023-06-30 $3.34 $3.47 $3.29 $3.39 4 318 893
2023-06-29 $3.38 $3.44 $3.31 $3.33 3 568 220
2023-06-28 $3.40 $3.46 $3.34 $3.39 3 864 076
2023-06-27 $3.41 $3.42 $3.30 $3.36 3 607 324
2023-06-26 $3.58 $3.58 $3.33 $3.39 5 873 424
2023-06-23 $3.70 $3.70 $3.50 $3.60 24 661 024
2023-06-22 $3.84 $3.84 $3.66 $3.68 3 709 907
2023-06-21 $3.84 $3.92 $3.79 $3.88 3 598 972
2023-06-20 $3.69 $3.89 $3.67 $3.87 4 865 904
2023-06-16 $3.95 $3.95 $3.66 $3.73 13 216 835
2023-06-15 $3.95 $3.98 $3.80 $3.92 4 116 485
2023-06-14 $4.07 $4.10 $3.94 $4.02 3 262 705
2023-06-13 $4.05 $4.18 $3.96 $4.06 4 324 651
2023-06-12 $4.05 $4.26 $3.93 $3.99 6 508 118
2023-06-09 $3.95 $4.03 $3.88 $3.98 4 592 870
2023-06-08 $3.78 $4.00 $3.74 $3.93 5 127 924
2023-06-07 $3.76 $3.80 $3.67 $3.76 3 279 690
2023-06-06 $3.65 $3.73 $3.60 $3.73 2 763 822
2023-06-05 $3.50 $3.66 $3.47 $3.63 2 843 767
2023-06-02 $3.54 $3.55 $3.40 $3.52 2 947 095
2023-06-01 $3.33 $3.56 $3.23 $3.50 3 468 521
2023-05-31 $3.24 $3.37 $3.20 $3.34 4 130 312
2023-05-30 $3.24 $3.47 $3.19 $3.23 3 889 737
Click to get the best stock tips daily for free!

About Ardelyx

Ardelyx Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult pat... ARDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT